AIVITA Biomedical and University of California at Irvine Collaborators Validate 3D Printed Bioreactor for Retinal Organoid Creation

IRVINE, Calif.: IRVINE, Calif., July 13, 2021 /PRNewswire/ -- AIVITA Biomedical, Inc., a private biotechnology company specializing in innovative stem cell applications, today announced the publication of the peer-reviewed manuscript, "Retinal organoids on-a-chip: a 3D printed micro-millifluidic bioreactor for long-term retinal organoid maintenance," in the journal Lab on a Chip....

Click to view original post